ubrogepant
Medicating Migraine in Prodrome Can Avert Headache, Facilitate Functioning
Ubrogepant taken in the prodrome phase of migraine was superior to placebo in staving off an acute episode, and in ...
DECEMBER 26, 2024
FDA Approves First-in-Class Ubrogepant for Acute Migraine Treatment
Ubrogepant becomes the first oral calcitonin gene–related peptide receptor antagonist approved for acute ...
DECEMBER 27, 2019
Ubrogepant Found Safe and Effective for Acute Migraine Symptoms in Trials
A significantly higher proportion of patients treated with an oral CGRP antagonist achieved freedom from pain and ...
DECEMBER 12, 2019
Load more